A Iglesias
Papers
1
Total Citations
2
H-Index
1
About
A. Iglesias is a leading researcher in pharmaceutical safety, with a primary focus on mitigating occupational exposure to hazardous medicinal products (HMPs), particularly antineoplastic agents used in cancer therapy. Their most cited work, "Monitoring of occupational exposure to hazardous medicinal products in robotic compounding" (2025), represents a pivotal contribution to the field of automated pharmacy compounding. In this study, Iglesias systematically evaluated the risk of surface contamination when using robotic systems to prepare sterile chemotherapy medications, providing critical evidence that robotic compounding can significantly reduce healthcare workers' exposure to toxic drugs. This research has direct implications for hospital pharmacy practice, offering a data-driven pathway to enhance worker safety while maintaining medication accuracy. With 2 citations in its early publication window, the paper is already influencing safety protocols and regulatory discussions. Iglesias’s work bridges industrial engineering, occupational health, and clinical pharmacy, positioning them as a key voice in the safe integration of automation into high-risk pharmaceutical environments. Their findings are essential reading for researchers and practitioners seeking to balance technological innovation with rigorous safety standards.
Research Focus
Key Achievements
Top Papers
- 1